EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Successful subcutaneous desensitization in a patient with systemic reaction due to ixekizumab

Diego Gutiérrez-Fernández iD, Mónica Saldaña-Valderas iD, Marianela Iriarte-Gahete iD, Raquel De la Varga-Martínez iD, Rafael Pamies-Espinosa iD, Jose Carlos Roldán-Morales iD, Zahira Maria Franzón-Laz iD, Joan Doménech-W

Revista Alergia México · 2025

DOI: 10.29262/ram.v72i1.1424 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Revista Alergia México, 2025. Verfasst von Diego Gutiérrez-Fernández und 7 weiteren Autor:innen. Beteiligte Einrichtung: PhD. Allergy Department. Puerta del Mar Univer-sitary Hospital, Cadiz, Spain. Hauptthemen laut MEDLINE: Desensitization, Immunologic, Antibodies, Monoclonal, Humanized, Drug Hypersensitivity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ixekizumab is a high-affinity IgG4 monoclonal humanized antibody useful for the treatment of ankylosing spondylitis. Benign skin reactions are a common adverse event with ixekizumab but systemic hypersensitivity reactions are much more unusual. Case report: We describe the case of a 54-female patient with HLAB27+ spondyloarthritis. Treatment with ixekizumab 80 mg subcutaneous (containing polysorbate) was prescribed. The patient experienced immediate severe dyspnea, skin erythema and flushing. Intradermal test (0.8 mg/ml) was clearly positive in the immediate reading. The patient was planned to undergo ixekizumab desensitization according to an 8-step protocol with good tolerance.

Conclusion

We report a patient with HLAB27+ spondyloarthritis treated with ixekizumab who developed a systemic IgE-mediated reaction. A successful and easy to perform subcutaneous desensitization protocol is described. Keywords: Hypersensitivity; Ixekizumab; Systemic reaction; Skin test; Desensitization protocol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Desensitization, ImmunologicAntibodies, Monoclonal, HumanizedDrug HypersensitivityHumansFemaleMiddle AgedInjections, SubcutaneousSpondylitis, Ankylosing

Stichwörter der Autor:innen

Desensitization protocolHypersensitivityIxekizumabSkin testSystemic reaction

Substanzen

ixekizumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • PhD. Allergy Department. Puerta del Mar Univer-sitary Hospital, Cadiz, Spain.
  • PhD. Pharmacy Department, Puerta del Mar Universitary Hospital, Cadiz, Spain.
  • Md. Immunology Department, Puerta del Mar Universitary Hospital, Cadiz, Spain.
  • Immunology Department, Puerta del Mar Uni-versitary Hospital, Cadiz, Spain.
  • MD. Allergy Department, Regional Universitary Hospital, Málaga, Spain.
  • Pharmacy Department, Puerta del Mar Universi-tary Hospital, Cadiz, Spain.

ORCID-Profile: Diego Gutiérrez-Fernández, Mónica Saldaña-Valderas, Marianela Iriarte-Gahete, Raquel De la Varga-Martínez, Rafael Pamies-Espinosa, Jose Carlos Roldán-Morales, Zahira Maria Franzón-Laz

Zitieren

APA

Gutiérrez-Fernández, D., Saldaña-Valderas, M., Iriarte-Gahete, M., De la Varga-Martínez, R., Pamies-Espinosa, R., Roldán-Morales, J. C., Franzón-Laz, Z. M., & Doménech-W, J. (2025). Successful subcutaneous desensitization in a patient with systemic reaction due to ixekizumab. Revista Alergia México. https://doi.org/10.29262/ram.v72i1.1424

Vancouver

Gutiérrez-Fernández D, Saldaña-Valderas M, Iriarte-Gahete M, De la Varga-Martínez R, Pamies-Espinosa R, Roldán-Morales JC, et al. Successful subcutaneous desensitization in a patient with systemic reaction due to ixekizumab. Revista Alergia México. 2025. doi:10.29262/ram.v72i1.1424

BibTeX
@article{GutirrezFernndez2025,
  author = {Gutiérrez-Fernández, Diego and Saldaña-Valderas, Mónica and Iriarte-Gahete, Marianela and De la Varga-Martínez, Raquel and Pamies-Espinosa, Rafael and Roldán-Morales, Jose Carlos and Franzón-Laz, Zahira Maria and Doménech-W, Joan},
  title = {Successful subcutaneous desensitization in a patient with systemic reaction due to ixekizumab},
  journal = {Revista Alergia México},
  year = {2025},
  doi = {10.29262/ram.v72i1.1424}
}
Kostenlos starten →